Resveratrol: Molecular Mechanisms, Health Benefits, and Potential Adverse Effects
Top Cited Papers
Open Access
Abstract
Resveratrol (RES), a naturally occurring polyphenolic compound, has garnered significant attention due to its diverse biological activities, which include anti‐inflammatory, antioxidant, and antiaging properties. This review synthesizes current evidence concerning the molecular mechanisms, therapeutic efficacy, and safety profile of RES across a variety of pathologies, with an emphasis on the latest research conducted in recent years. Mechanistically, RES is known to modulate critical signaling pathways such as the activation of sirtuin 1. These actions collectively contribute to the attenuation of oxidative stress, regulation of apoptosis, and promotion of autophagy. Preclinical studies have demonstrated the potential of RES in the mitigation of degenerative musculoskeletal disorders, cardiovascular diseases, cancer progression, and neurological diseases. Given the low bioavailability of RES and the potential for adverse reactions in clinical applications, we summarize and discuss its safety profile while outlining future research directions. This review underscores the therapeutic versatility of RES while advocating for rigorous pharmacokinetic optimization, standardized dosing protocols, and large‐scale randomized controlled trials to validate its efficacy and safety in human populations.Keywords
Funding Information
- National Natural Science Foundation of China (82272611, 92268115, 82472522)
- Natural Science Foundation of Hunan Province (2023JJ30949)
This publication has 254 references indexed in Scilit:
- Resveratrol Prolongs Lifespan and Retards the Onset of Age-Related Markers in a Short-Lived VertebrateCurrent Biology, 2006
- Inhibition of mammalian DNA polymerases by resveratrol: mechanism and structural determinantsBiochemical Journal, 2005
- Induction of prosurvival molecules by apoptotic stimuli: involvement of FOXO3a and ROSOncogene, 2005
- HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANSDrug Metabolism and Disposition, 2004
- Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespanNature, 2003
- Protective effect of trans-resveratrol against kainic acid-induced seizures and oxidative stress in ratsPharmacology Biochemistry and Behavior, 2002
- Occurrence of resveratrol and pterostilbene in age-old darakchasava, an ayurvedic medicine from IndiaJournal of Ethnopharmacology, 1999
- Is Resveratrol an Estrogen Agonist in Growing Rats?**This work was supported by NIH Grant AA-11140 and the Mayo Foundation.Endocrinology, 1999
- Resveratrol, a remarkable inhibitor of ribonucleotide reductaseFEBS Letters, 1998
- Wine, alcohol, platelets, and the French paradox for coronary heart diseaseThe Lancet, 1992